Wall St. Watchdog reveals information about today’s action in the Healthcare (NYSE:XLV) sector:

Gainers (% price change)

• Gentiva Health Services (NASDAQ:GTIV): The shares closed at $5.34, up $0.79, or 17.36%, on the day. Its market capitalization is $163.45 million. About the company: Gentiva Health Services, Inc. provides specialty pharmaceutical and home health care services. The company provides products and services for hemophilia and bleeding disorders, growth hormone deficiency, RSV prevention and nutritional support services. Gentiva also provides services for diabetes, cardiovascular conditions, post-surgical care, orthopedic rehabilitation and other diseases. Get the most recent company news and stock data here >>
• Salix Pharmaceuticals (NASDAQ:SLXP): The shares closed at $36.72, up $2.07, or 5.97%, on the day. Its market capitalization is $2.17 billion. About the company: Salix Pharmaceuticals, Ltd. develops and markets prescription pharmaceutical products for the treatment of gastrointestinal diseases. The Company markets its products to gastroenterologists in the U.S. through its own specialty sales force. Get the most recent company news and stock data here >>
• (): The shares closed at $52.92, up $2.51, or 4.98%, on the day. Its market capitalization is $130.57 million. Get the most recent company news and stock data here >>
• Aastrom Biosciences, Inc. (NASDAQ:ASTM): The shares closed at $2.70, up $0.06, or 2.27%, on the day. Its market capitalization is $104.29 million. About the company: Aastrom Biosciences, Inc. develops autologous stem/progenitor cell products for the repair/regeneration of tissues based on Tissue Repair Cell (NYSE:TRC) adult stem cell technology. The Company’s products contain bone marrow stem and progenitor cells that are produced from cells originating from the patient. Get the most recent company news and stock data here >>
• Optimer Pharmaceuticals (NASDAQ:OPTR): The shares closed at $11.20, up $0.24, or 2.19%, on the day. Its market capitalization is $522.43 million. About the company: Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer’s initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance. Get the most recent company news and stock data here >>

Losers (% price change)

• ISTA Pharmaceuticals, Inc (NASDAQ:ISTA): The shares closed at $4.03, down $0.55, or 12.01%, on the day. Its market capitalization is $168.69 million. About the company: Ista Pharmaceuticals, Inc. develops proprietary therapeutic products that save and improve eyesight. The Company’s product candidates and programs address diseases and conditions such as vitreous hemorrhage, diabetic retinopathy, glaucoma, ocular pain, and inflammation. Get the most recent company news and stock data here >>
• Pharmacyclics, Inc. (NASDAQ:PCYC): The shares closed at $11.49, down $1.23, or 9.67%, on the day. Its market capitalization is $785.92 million. About the company: Pharmacyclics, Inc. is a pharmaceutical company developing products to improve upon current therapeutic approaches to cancer, atherosclerosis, and retinal disease. The Company’s products are patented agents derived from its technology platform for designing and synthesizing energy-potentiating drugs. Get the most recent company news and stock data here >>
• Rockwell Medical Tech (NASDAQ:RMTI): The shares closed at $7.07, down $0.73, or 9.36%, on the day. Its market capitalization is $131.97 million. About the company: Rockwell Medical Technologies, Inc. manufactures, markets, and delivers dialysis solutions, powders, and ancillary products to hemodialysis providers. The Company offers Dri-State Dry Acid, Liquid Acid, SteriLyte Liquid Bicarbonate, Powder Bicarbonate, and ancillary dialysis items. Rockwell’s products are used to cleanse a patient’s blood and replace nutrients in the bloodstream. Get the most recent company news and stock data here >>
• DepoMed, Inc. (NASDAQ:DEPO): The shares closed at $4.41, down $0.44, or 9.07%, on the day. Its market capitalization is $244.31 million. About the company: DepoMed, Inc. develops new and proprietary oral drug delivery technologies. The Company has developed a system designed to be retained in the stomach for an extended period of time while it delivers the incorporated drug or drugs. DepoMed has also developed a system designed to reduce gastrointestinal irritation. Get the most recent company news and stock data here >>
• Sucampo Pharmaceuticals (NASDAQ:SCMP): The shares closed at $3.63, down $0.34, or 8.56%, on the day. Its market capitalization is $152.02 million. About the company: Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation. Get the most recent company news and stock data here >>

(Note: Selected financial data are sourced from Google Finance. All data are assumed to be accurate.)

Advantage: Check out our interactive stock charts, fundamentals, Twitter stream, and more >>

Improve Your 2011 Financial Health: Join the winning team of stock pickers with Wall St. Cheat Sheet’s acclaimed premium newsletter>>

Get Your FREE Special Report: 4 Things You Must Know About the US Economy Now!